Tocilizumab and COVID-19: Timing of Administration Assessment

Q. Richier; V. Jachiet; V. Bonnemains; L. Plaçais; N. Abisror; M. Garnier; J. Pacanowski; R. Dhote; O. Hinchschberger; M. Michel; B. Bienvenu; C. Comarmond; K. Lacombe; A. Mekinian

doi:10.1016/j.idnow.2021.06.304

Journal Articles Infectious Diseases Now Year : 2022

Tocilizumab and COVID-19: Timing of Administration Assessment

(1, 2) , (3) , (3) , (4) , (3) , (3) , (2) , (5) , (6) , (7) , (8) , (3) , (1, 2) , (3)

1
2
3
4
5
6
7
8

Q. Richier

Function : Author

Institut Pierre Louis d'Epidémiologie et de Santé Publique

CHU Saint-Antoine [AP-HP]

V. Jachiet

Function : Author
PersonId : 1210142
ORCID : 0000-0002-1163-9796
IdRef : 273433431

CHU Pitié-Salpêtrière [AP-HP]

V. Bonnemains

Function : Author

CHU Pitié-Salpêtrière [AP-HP]

L. Plaçais

Function : Author

Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]

N. Abisror

Function : Author

CHU Pitié-Salpêtrière [AP-HP]

M. Garnier

Function : Author

CHU Pitié-Salpêtrière [AP-HP]

J. Pacanowski

Function : Author

CHU Saint-Antoine [AP-HP]

R. Dhote

Function : Author

Hôpital Avicenne [AP-HP]

O. Hinchschberger

Function : Author

Centre Hospitalier Emile Muller [Mulhouse]

M. Michel

Function : Author

CHU Henri Mondor [Créteil]

B. Bienvenu

Function : Author

Hôpital Saint-Joseph [Marseille]

C. Comarmond

Function : Author

CHU Pitié-Salpêtrière [AP-HP]

K. Lacombe

Function : Author

Institut Pierre Louis d'Epidémiologie et de Santé Publique

CHU Saint-Antoine [AP-HP]

A. Mekinian

Function : Author
PersonId : 818189
ORCID : 0000-0003-2849-3049
IdRef : 131898493

CHU Pitié-Salpêtrière [AP-HP]

Domains

Human health and pathology

Fichier principal

S2666991921004206.pdf (291.2 Ko)

Origin	Files produced by the author(s)

Accord Elsevier CCSD : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03707363

Submitted on : Monday, July 22, 2024-11:01:57 AM

Last modification on : Monday, July 22, 2024-11:01:57 AM

Dates and versions

hal-03707363 , version 1 (22-07-2024)

Licence

Attribution - NonCommercial

Identifiers

HAL Id : hal-03707363 , version 1
DOI : 10.1016/j.idnow.2021.06.304
PII : S2666-9919(21)00420-6
PUBMEDCENTRAL : PMC8239201

Cite

Q. Richier, V. Jachiet, V. Bonnemains, L. Plaçais, N. Abisror, et al.. Tocilizumab and COVID-19: Timing of Administration Assessment. Infectious Diseases Now, 2022, 52 (1), pp.31--34. ⟨10.1016/j.idnow.2021.06.304⟩. ⟨hal-03707363⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM IPLESP SORBONNE-UNIVERSITE SU-MEDECINE

49 View

2 Download

Tocilizumab and COVID-19: Timing of Administration Assessment

Domains

Dates and versions

Licence

Identifiers

Cite

Export

Collections

Altmetric

Share